Filing Details

Accession Number:
0001209191-18-062349
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-12 20:30:06
Reporting Period:
2018-12-10
Accepted Time:
2018-12-12 20:30:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1708599 Agex Therapeutics Inc. AGE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202529 D Michael West 1010 Atlantic Avenue, Suite 102
Alameda CA 94501
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Acquisiton 2018-12-10 4,000 $3.86 15,460 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price of $3.8607 per share represents a weighted average of prices ranging from $3.8566 to $3.8634 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.